Incentives for Research, Development, and Innovation in Pharmaceuticals: Series economia de la salud y gestion sanitaria
Editat de Walter A. Garcia-Fontesen Limba Engleză Paperback – 12 ian 2012
Preț: 352.20 lei
Preț vechi: 370.73 lei
-5% Nou
Puncte Express: 528
Preț estimativ în valută:
67.40€ • 70.78$ • 55.86£
67.40€ • 70.78$ • 55.86£
Carte tipărită la comandă
Livrare economică 16-30 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9788493806217
ISBN-10: 8493806218
Pagini: 108
Ilustrații: IX, 96 p.
Dimensiuni: 170 x 240 x 6 mm
Greutate: 0.19 kg
Ediția:2011
Editura: Springer
Colecția Springer Healthcare
Seria Series economia de la salud y gestion sanitaria
Locul publicării:Madrid, Spain
ISBN-10: 8493806218
Pagini: 108
Ilustrații: IX, 96 p.
Dimensiuni: 170 x 240 x 6 mm
Greutate: 0.19 kg
Ediția:2011
Editura: Springer
Colecția Springer Healthcare
Seria Series economia de la salud y gestion sanitaria
Locul publicării:Madrid, Spain
Public țintă
Professional/practitionerCuprins
Introduction.- Incentives for innovation: a survey.- Incentives for innovation: neglected diseases.- When patents are not enough: supplementary incentives for pharmaceutical innovation.- The Contribution of the United States, Europe and Japan in Discovering New Drugs: 1982 2003.- The use of pay for performance for drugs: can it improve incentives for innovation?.- Drug Price Regulation: Recent Trends and Downstream Neglected Issues.
Notă biografică
Walter Garcia-Fontes is an associate professor at the Department of Economics and Business of Universitat Pompeu Fabra. His research interests are in Industrial Organization, firm innovation, technological change and applied econometrics. He has published his work in leading international field journals. He has coordinated various projects in the European Commission Framework Programmes studying the European chemical industry and the organizational changes related to new industrial relations.
Textul de pe ultima copertă
Incentives for innovation are particularly relevant in the pharmaceutical
industry where not all social needs provide equally profitable
opportunities and where most OECD countries try to implement diffe -
rent measures that promote research in these less profitable areas. The
lack of incentives for innovation is especially dramatic when we take
into account diseases affecting mostly low-income countries, and also
diseases affecting small groups of patients.
How can incentives be provided to deal with these less profitable acti -
vities when no clear markets exist for the innovations being introduced?
Some of the contributions of this book go into discussing alternative
mechanisms to substitute for these inexistent markets, and
situations where traditional instruments such as public procurement or
direct subsidies have proven totally insufficient. Also, this book discusses
the clear mismatch between the size of the markets being targeted and
the incentives being provided.
industry where not all social needs provide equally profitable
opportunities and where most OECD countries try to implement diffe -
rent measures that promote research in these less profitable areas. The
lack of incentives for innovation is especially dramatic when we take
into account diseases affecting mostly low-income countries, and also
diseases affecting small groups of patients.
How can incentives be provided to deal with these less profitable acti -
vities when no clear markets exist for the innovations being introduced?
Some of the contributions of this book go into discussing alternative
mechanisms to substitute for these inexistent markets, and
situations where traditional instruments such as public procurement or
direct subsidies have proven totally insufficient. Also, this book discusses
the clear mismatch between the size of the markets being targeted and
the incentives being provided.
Caracteristici
In-depth discussion of neglected health economics issues Includes up to date analysis of new data Written by a collection of the leading minds in the field Ground breaking ideas to enhance research and development in the pharmaceutical industry